FDA Announces Veterinary AMR Performance Measures on FDA-TRACK

The site includes graphic illustrations showing trends associated with the five-year plan.
The site includes graphic illustrations showing trends associated with the five-year plan.
(FDA)

Today the U.S. Food and Drug Administration is announcing the availability of performance measures that  track the progress of the Center of Veterinary Medicine’s (CVM) Five-Year Plan for Supporting Antimicrobial Stewardship in Veterinary Settings. This information is part of FDA-TRACK, a tool that promotes transparency and monitors certain FDA programs through performance measures and projects. 

CVM’s five-year plan is organized under three goals:

  1. Align antimicrobial drug product use with the principles of antimicrobial stewardship.
  2. Foster stewardship of antimicrobials in veterinary settings.
  3. Enhance monitoring of antimicrobial resistance and antimicrobial drug use in animals.

For the first update, FDA has provided information for key projects within Goal One of CVM’s five-year plan. Key projects for Goal One include: bringing all dosage forms of medically important antimicrobial drugs approved for use in animals under veterinary oversight, ensuring that medically important antimicrobial drugs used in the feed or drinking water of food-producing animals have a defined duration of use, and updating the list of medically important antimicrobials. 

Information in FDA-TRACK will be updated on a semi-annual basis for each project. Key projects and performance measures for Goal Two and Goal Three of CVM’s five-year plan are under development and will be made available in the coming year. 

Additional Information from USDA:

FDA-TRACK: Progress on FDA’s Support of Antimicrobial Stewardship in Veterinary Settings

FDA-TRACK Homepage

Antimicrobial Resistance

For more on USDA’s antimicrobial stewardship initiatives, see these articles from BovineVetOnline:

FDA Plans Next Moves on Antimicrobials

FDA Funds Duration of Use Studies

FDA Releases Draft GFI to End OTC Sales of Most Animal Antibiotics

 

Latest News

Properly Prepared Beef Remains Safe; Meat Institute Calls For Guidance to Protect Workers at Beef Facilities
Properly Prepared Beef Remains Safe; Meat Institute Calls For Guidance to Protect Workers at Beef Facilities

The Meat Institute said properly prepared beef remains safe to eat and called for USDA and the CDC to provide worker safety guidance specific to beef processors to ensure workers are protected from infection.

 A Message to the Ag Industry about H5N1
A Message to the Ag Industry about H5N1

The livestock industry needs a comprehensive, cohesive plan to address the virus. Producers, their employees and veterinarians need clear answers and support from U.S. agricultural leadership, moving forward.

USDA Now Requiring Mandatory Testing and Reporting of HPAI in Dairy Cattle as New Data Suggests Virus Outbreak is More Widespread
USDA Now Requiring Mandatory Testing and Reporting of HPAI in Dairy Cattle as New Data Suggests Virus Outbreak is More Widespread

USDA is now ordering all dairy cattle must be tested prior to interstate travel as a way to help stop the spread of HPAI H5N1. This comes a day after FDA confirmed virus genetic material was found in retail milk samples.

Mistrial Declared in Arizona Rancher’s Murder Trial
Mistrial Declared in Arizona Rancher’s Murder Trial

A lone juror stood between rancher George Kelly and innocent. “It is what it is, and it will be what it will be. Let me go home, okay?”

USDA Shares Recent H5N1 Avian Flu Sequences
USDA Shares Recent H5N1 Avian Flu Sequences

APHIS announced it has shared 239 genetic sequences of the H5N1 avian flu virus which will help scientists look for new clues about the spread of the virus.

Fairlife Breaks Ground on $650 Million Facility in New York
Fairlife Breaks Ground on $650 Million Facility in New York

Fairlife is known for its value-added dairy products, such as ultra-filtered milk, protein shakes and lactose-free milk. Soon, the company will be producing these popular products at its upcoming facility in N.Y.